Human epidermal growth factor receptor 2 (HER2; also called Her-2/neu or ErbB2) is a member of the transmembrane epidermal growth factor receptor family and is one of the most studied TAAs for cancer immunotherapy. Here, ERBB2 is linked to cancer.